28 March 2015

Plethora treatment wins NHS approval

15/04/2011 Ben Jaglom

Specialist pharmaceutical concern Plethora Solutions Holdings (PLE) says it has won approval for its vaginal dryness treatment Hyalofemme from the NHS for prescription.

The agreement means that doctors in the UK will now be able to write prescriptions for Hyalofemme for the first time for atrophic vaginitis, commonly referred to as vaginal dryness. Traditional treatments involve the use of hormonal creams containing estrogen, but such creams are often inappropriate for cancer patients, who often suffer vaginal dryness as a side effect of cancer treatment.

Chairman Bill Robinson remarks the decision by the NHS should 'increase the commercial value of our pipeline by exploiting products secured last year'. He adds that the release of Hyalofemme is an 'important treatment' for atrophic vaginitis.

Following the announcement analysts at house broker Daniel Stewart held their forecasts of a year-end loss of £1.3 million (2010: loss of £1.5 million) on revenue up £100,000 to £1.2 million. They have pencilled in a loss per share of 2.5p for 2011 and a further loss of 3.4p a share for 2012.

Shares in Plethora were up 0.25p this morning following the announcement to 7.5p, the price at which Growth Company Investor recommended them earlier this month. A good sign for the company's prospects, Hyalofemme will be prescribed both for those being treated for cancer and women going through the menopause. We therefore reiterate our speculative buy rating.

Tags: AIM market, Menopause, Pharma, Plethora Solutions Holdings, Urology Company, Vaginal dryness

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2014

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1,044 AIM-quoted companies. The full report is available to order for £365 + VAT. Click here for more info

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

The company received the proceeds as part of a wider consortium

652k on the Horizon 26/03/2015

Horizon Discovery Group (AIM:HZD), a provider of research tools and services for genomics research, has received £652,000 as part of a consortium. 

Tags: Biotech, Fundraising

Pantheon drilling ahead 26/03/2015

AIM-quoted US-focused oil and gas play Pantheon Resources (AIM:PANR) has updated investors on its latest activities.

Tags: Oil and gas, USA

Petroceltic leaving Kurdistan 26/03/2015

Irish oil explorer Petroceltic International (AIM:PCI) reported that it was ending its involvement in the Kurdistan region of Iraq.

Tags: Iraq, Oil and gas

Plexus Holdings announces Chinese deal 26/03/2015

Scottish oil technology specialist Plexus Holdings (AIM:POS) has announced a partnership with Chinese oil services provider Yantai Jereh.

Tags: China, Oil and gas

AFC wins German permit 26/03/2015

Alkaline fuel cell developer AFC Energy (AIM:AFC) has won a permit to build the 'world's first alkaline fuel cell facility' in Germany.

Tags: Germany

Karelian makes major find 20/03/2015

Finland-focused Karliean Diamonds (AIM:KDR) has discovered a potential new diamond source.

Tags: Diamond mining

More News